Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Notice to convene Annual General Meeting


Posted on: 19 Mar 18

Orphazyme A/S
Company announcement

No. 04/2018                                                                                 

Copenhagen, Denmark, March 19, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the Orphazyme A/S Annual General Meeting will be held on:

Thursday, April 12, 2018 at 5:00 PM (CET)

at Gorrissen Federspiel Advokatpartnerselskab, Axeltorv 2, DK-1609 Copenhagen V.

The notice to convene the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors, is attached.

Additional information about the Annual General Meeting is available at Orphazyme A/S’ website, http://phx.corporate-ir.net/phoenix.zhtml?c=254662&p=irol-agm.

 

For additional information, please contact

 

Orphazyme A/S

Anders Vadsholt, CFO                         +45 28 98 90 55

About Orphazyme A/S
Orphazyme is a Danish biopharmaceutical company focused on the development of treatments for patients living with life-threatening or debilitating rare diseases. Our research is concentrated on the cell-protective properties of the body’s own rescue system for diseases caused by misfolded proteins or lysosomal dysfunction. The company’s lead candidate, arimoclomol, is in development for four severe orphan diseases; two muscle-wasting diseases, sporadic Inclusion Body Myositis (sIBM) and Amyotrophic Lateral Sclerosis (ALS), and two lysosomal storage diseases, Niemann-Pick disease Type C (NPC) and Gaucher disease. We are listed on Nasdaq Copenhagen (ORPHA.CO). For more information, please visit www.orphazyme.com.

 

04-2018 Notice to convene Annual General Meeting

Notice to Convene Annual General Meeting

Appendix 1

GlobeNewswire
globenewswire.com

Last updated on: 19/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.